INFORMATION BY CANCER TYPE

Bladder

Antidiabetic Agent Linked to Increased Risk of Bladder Cancer
BY Allie Casey
The FDA recently issued a warning that a type of medicine used to treat Type 2 diabetes may increase a person's risk for developing bladder cancer.
Tecentriq Gets FDA Priority Review for New Use In Bladder Cancer
BY Jason M. Broderick
Tecentriq (atezolizumab) is being reviewed for the use in additional settings to treat bladder cancer.
FDA Grants Durvalumab Priority Review for Bladder Cancer
BY Jason M. Broderick
The  PD-L1 inhibitor durvalumab was granted a priority review for the treatment of some patients with urothelial carcinoma. 
In the Age of Immunotherapy, Chemotherapy Is Still a Mainstay for Bladder Cancer
BY Gina Columbus
As immunotherapy's potential continues to grow in the treatment of bladder cancer, Gopa Iyer, M.D., says that more research needs to be done before it becomes the next new standard.
Bladder Cancer Treatments Continue to Evolve
BY Allie Strickler
The treatment landscape of bladder cancer drastically changed this spring with the approval of an immunotherapy agent, and will continue to shift in the months and years to come.
Popular Bladder Cancer Drug Production Halts, Worrying Patients, Physicians
BY Ariela Katz
One company's production of a popular bladder cancer therapy is set to halt by mid-2017, generating worries from patients and oncologists that there will be a shortage. 
Immunotherapy Combination Shows Promise in Bladder Cancer
BY Silas Inman
The combination of Opdivo and Yervoy is showing promise in the treatment of bladder cancer, according to a recent study.
Leveling the Playing Field for LGBT Patients
BY Beth Fand Incollingo
The National LGBT Cancer Network is making cancer screenings more available to a high-risk, underserved population.
 
Experts Discuss Immunotherapy's Role in the Shifting Landscape in Solid Tumors
A panel of experts recently discussed the evolving field of immunotherapy for solid tumor types.
Immunotherapy Will Be the Norm in Bladder Cancer Care
BY Gina Columbus
When it comes to bladder cancer, PD-1 and PD-L1 agents will become the new mainstay, says Jonathan E. Rosenberg, M.D.
Special Feature
Share Your Art
Talk about this article with other patients, caregivers, and advocates in the Bladder CURE discussion group.
Search Cancer Drugs & Terms
Treatment
Information about treatment, including surgery, chemotherapy, radiation therapy, immunotherapy, and vaccine therapy
Bladder Cancer Treatment (PDQ®)
Expert-reviewed information summary about the treatment of bladder cancer.
Gallbladder Cancer Treatment (PDQ®)
Expert-reviewed information summary about the treatment of gallbladder cancer.